Aura Biosciences, Inc. (AURA) Live Share Price, Invest From India

Aura Biosciences, Inc. Stock Performance

as on October 18, 2025 at 1:29 am IST

Day's Low
Day's High
$5.55
Day's Price Range
$6.2
$5.66
1.94%
Downside
9.54%
Upside
52 Week's Low
52 Week's High
$4.35
52-Week Price Range
$12.38
$5.66
23.23%
Downside
118.70%
Upside

Aura Biosciences, Inc. share price movements today

Previous Close: $6.19
Open: $6.20
Volume: 865.5K
Day's Low - High: $5.55 - $6.2
52 Week Low - High: $4.35 - $12.38

Aura Biosciences, Inc. Historical Returns

1 Month Return: -9.42 %
3 Month Return: -15.5 %
1 Year Return: -51.7 %
3 Year Return: -57.65 %
5 Year Return: 0 %

Aura Biosciences, Inc. Stock Fundamentals & Key Indicators

Check Aura Biosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$384.5M

EPS (TTM)

-2.0517

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-107.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

1742900.00%

Aura Biosciences, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aura Biosciences, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Aura Biosciences, Inc.	BUY	$384.5M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$63.1B	231.27%	-505.15	-12.96%
Beone Medicines Ltd	NA	$36.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$104.8B	91.13%	29.04	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.3B	-3.62%	14.35	31.37%

Stock Returns calculator for Aura Biosciences, Inc. Stock including INR - Dollar returns

The Aura Biosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Aura Biosciences, Inc. investment value today

Current value as on today

₹53,006

Returns

₹46,994

(-46.99%)

Returns from Aura Biosciences, Inc. Stock

₹51,789 (-51.79%)

Dollar Returns*

₹4,794 (+4.79%)

Analyst Recommendation on Aura Biosciences, Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Aura Biosciences, Inc.. Average target price of $21.2

Aura Biosciences, Inc. Share Price Target

Get share price movements and forecasts by analysts on Aura Biosciences, Inc..

What analysts predicted

73.3%UPSIDE

Target Price

$21.2

Current Price

$5.66

Analyzed by

12 Analysts

Target

$21.20

Aura Biosciences, Inc. target price $21.2, a slight upside of 73.3% compared to current price of $5.66. According to 12 analysts rating.

Aura Biosciences, Inc. Stock’s Investor Sentiment and Interest

Search interest for Aura Biosciences, Inc. Stock has increased by 93% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 18, 2025 to October 18, 2025

Change:93% versus previous 30 day period

Aura Biosciences, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	2	2	-	-	1	-	-
Gross Profit	0	0	0	1	0	0	0	0	0	0
Operating Income	-19	-20	-20	-24	-22	-22	-23	-27	-29	-28
EBITDA	-19	-19	-20	-24	-22	-22	-22	-27	-27	-26
Interest Expense	2	-	-	2	2	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-17	-18	-18	-21	-19	-20	-20	-25	-27	-26
Income Tax Expense	-2	-2	0	0	0	0	0	0	0	0
Net Income	-15	-18	-18	-22	-19	-20	-21	-25	-27	-27
Net Profit Margin	0.00%	0.00%	0.00%	-1076.41%	-958.46%	0.00%	0.00%	-2086.75%	0.00%	0.00%

Aura Biosciences, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	0	-1	-1	-1
Operating Income	-24	-22	-35	-60	-84	-96
EBITDA	-23	-21	-34	-59	-83	-85
Interest Expense	0	0	0	0	-	-
Depreciation	0	0	0	1	1	1
Income Before Tax	-24	-22	-35	-58	-76	-86
Income Tax Expense	0	0	0	-1	0	0
Net Income	-24	-22	-35	-58	-76	-86
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Aura Biosciences, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-18	-18	-22	-19	-20	-21	-25	-27	-27
Operating Cash Flow	-14	-15	-17	-24	-16	-15	-23	-23	-20
Investing Cash Flow	21	21	-90	9	19	9	29	29	19
Financing Cash Flow	2	1	92	0	0	0	0	0	69
Change in Cash	9	7	-14	-14	3	-4	6	6	69

Aura Biosciences, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-22	-35	-58	-76	-86
Operating Cash Flow	-24	-32	-54	-63	-79
Investing Cash Flow	0	-2	-67	-113	68
Financing Cash Flow	10	166	95	97	1
Change in Cash	-15	131	-26	-80	-9

Global Institutional Holdings in Aura Biosciences, Inc.

Funds	Holdings
Matrix Capital Management Company, LLC	11.14%
Adage Capital Partners Gp LLC	7.86%
Long Focus Capital Management, LLC	7.44%
Suvretta Capital Management, LLC	7.04%
BlackRock Inc	4.99%

See all

Insights on Aura Biosciences, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 205.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 114.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, AURA stock has moved down by -4.2%

About Aura Biosciences, Inc.

at aura biosciences, we are developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach we call molecular surgery. by safely eliminating cancer locally, we can treat early and transform the lives of people with a wide range of cancers that are poorly managed today. our lead program in ocular melanoma (om), also known as choroidal or uveal melanoma, is designed to remove cancer cells in the back of the eye as a first-line therapy, while allowing for the potential of preserving patients’ vision. the goal is to treat small ocular melanomas potentially long before the disease progresses and metastasizes to the liver, where it almost always is fatal. development of a first-in-class, non-radioactive treatment option to selectively destroy cancer cells would create the possibility to transform the treatment of this and other cancers where the disease can be detected early. by enabling physicians to treat cancer mo

Organisation	Aura Biosciences, Inc.
Headquarters	80 Guest Street, Boston, MA, United States, 02135
Industry	Healthcare
CEO	Dr. Elisabet de los Pinos Ph.D.
E-voting on shares	Click here to vote

Key Management of Aura Biosciences, Inc.

Name	Title
Dr. Jill J. Hopkins M.D.	Chief Medical Officer & President of Research and Development
Mr. Anthony S. Gibney	Chief Financial & Business Officer
Dr. Mark Plavsic D.V.M., Ph.D.	Chief Technology Officer
Dr. Anthony Daniels M.D.	VP & Therapeutic Area of Head Ocular Oncology
Dr. Sabine Brookman-May	Senior VP & Therapeutic Area Head of Urologic Oncology
Dr. Elisabet de los Pinos Ph.D.	Founder, CEO, President & Director
Mr. Conor Kilroy	Chief Legal Officer & Secretary
Ms. Amy Elazzouzi	Interim Principal Accounting Officer, Senior VP of Finance & Treasurer
Mr. Patrick Nealon	Senior Vice President of Clinical Development Operations
Dr. Richard Mountfield Ph.D.	Senior Vice President of Regulatory Affairs & Quality

FAQs

What is Aura Biosciences, Inc. share price today?

Aura Biosciences, Inc. share price today is $5.66 as on October 18, 2025 at 1:29 am IST at the close of the market. Aura Biosciences, Inc. share today touched a day high of $6.2 and a low of $5.55.

What is the 52 week high and 52 week low for Aura Biosciences, Inc. share?

Aura Biosciences, Inc. share touched a 52 week high of $12.38 on October 18, 2024 and a 52 week low of $4.35 on May 15, 2025. Aura Biosciences, Inc. stock price today i.e. October 18, 2025 at 1:29 am IST is closed at $5.66,which is 54.27% down from its 52 week high and 30.26% up from its 52 week low.

What is Aura Biosciences, Inc.'s market capitalisation today?

Aura Biosciences, Inc. market capitalisation is $0.00T as on October 18, 2025 at 1:29 am IST.

How to invest in Aura Biosciences, Inc. Stock (AURA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Aura Biosciences, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aura Biosciences, Inc. Shares that will get you 0.2650 shares as per Aura Biosciences, Inc. share price of $5.66 per share as on October 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aura Biosciences, Inc. Stock (AURA) from India?

Indian investors can start investing in Aura Biosciences, Inc. (AURA) shares with as little as ₹87.954 or $1 (as of October 18, 2025 at 9:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Aura Biosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on October 18, 2025 at 9:44 pm IST). Based on Aura Biosciences, Inc. share’s latest price of $5.66 as on October 18, 2025 at 1:29 am IST, you will get 1.7668 shares of Aura Biosciences, Inc.. Learn more about fractional shares .